578 filings
Page 6 of 29
DEFA14A
49ahk82dru21m3xx58
5 May 15
Additional proxy soliciting materials
12:00am
EFFECT
1xrgv8k x1ew
30 Apr 15
Notice of effectiveness
12:00am
POS AM
51y8hx0j
15 Apr 15
Prospectus update (post-effective amendment)
12:00am
8-K
v5wpca 3e11zbz1
3 Apr 15
Other Events
12:00am
424B5
2ez 8zbt8
2 Apr 15
Prospectus supplement for primary offering
12:00am
424B5
qg9e0
30 Mar 15
Prospectus supplement for primary offering
12:00am
EFFECT
p2non21x
30 Mar 15
Notice of effectiveness
12:00am
S-3ASR
p450qcwt
30 Mar 15
Automatic shelf registration
12:00am
CORRESP
x0snipl9arx2c5pcjtyt
26 Mar 15
Correspondence with SEC
12:00am
DEFA14A
2796zfbyjkr49
26 Mar 15
Additional proxy soliciting materials
12:00am
UPLOAD
n4mtb3ivq1rl502l 82
10 Mar 15
Letter from SEC
12:00am
S-8
bmz3plf op7tjsk
6 Mar 15
Registration of securities for employees
12:00am
POS AM
1dqbo1
2 Mar 15
Prospectus update (post-effective amendment)
12:00am
POSASR
0mso4fwx6aw lt5yfln
2 Mar 15
Automatic shelf registration (post-effective amendment)
12:00am
8-K
ammf0q mrn
26 Feb 15
Raptor Pharmaceutical Reports Fourth Quarter and Full Year 2014 Financial Results and Provides 2015 Corporate Update
12:00am
8-K
iwf71 ylruyt
13 Feb 15
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
12:00am
8-K
du2dzdx
7 Jan 15
Raptor Pharmaceutical Appoints Krishna Polu, M.D. as Chief Medical Officer and Michael Smith as Chief Financial Officer
12:00am